Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD001146.pub2PMID 19160190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth and Neurodevelopmental Outcomes After Early Low-Dose Hydrocortisone Treatment in Extremely Low Birth Weight Infants

  2007cited by this paper
• A Double-Blind, Randomized, Controlled Study of a “Stress Dose” of Hydrocortisone for Rescue Treatment of Refractory Hypotension in Preterm Infants

  2006cited by this paper
• Early Low-Dose Hydrocortisone in Very Preterm Infants: A Randomized, Placebo-Controlled Trial

  2006cited by this paper
• The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: A two‐year follow‐up study

  2005cited by this paper
• A Randomized-Controlled Trial of Prophylactic Hydrocortisone Supplementation for the Prevention of Hypotension in Extremely Low Birth Weight Infants

  2005cited by this paper
• Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapy

  2005cited by this paper
• Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants.

  2005cited by this paper
• Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter Trial

  2004cited by this paper
• Effect of Dexamethasone on Tracheobronchial Aspirate Fluid Cytology and Pulmonary Mechanics in Preterm Infants

  2004cited by this paper
• Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.

  2004cited by this paper
• Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.

  2003cited by this paper
• Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.

  2003cited by this paper
• Coronary Arteritis and Arterial Remodeling in Kawasaki Disease: Immunohistochemical Study

  2003cited by this paper
• Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.

  2003cited by this paper
• Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.

  2003cited by this paper
• Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.

  2002cited by this paper
• Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.

  2001cited by this paper
• Early Dexamethasone—Attempting To Prevent Chronic Lung Disease

  2000cited by this paper
• Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.

  2000cited by this paper
• Early postnatal dexamethasone treatment and increased incidence of cerebral palsy

  2000cited by this paper
• Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function

  2000cited by this paper
• Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.

  2000cited by this paper
• A Three-day Course of Dexamethasone Therapy to Prevent Chronic Lung Disease in Ventilated Neonates: A Randomized Trial

  1999cited by this paper
• Early Dexamethasone Therapy and Blood Cell Count in Preterm Infants

  1999cited by this paper
• Clinical Trials of Postnatal Corticosteroids: Inhaled and Systemic

  1999cited by this paper
• Postnatal dexamethasone in preterm infants

  1999cited by this paper
• Vascular Endothelial Growth Factor in Pulmonary Lavage Fluid from Premature Infants: Effects of Age and Postnatal Dexamethasone

  1999cited by this paper
• Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants

  1999cited by this paper
• A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants.

  1999cited by this paper
• Early dexamethasone treatment in preterm infants treated with surfactant: a double blind controlled trial.

  1999cited by this paper
• Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants.

  1999cited by this paper
• Effect on Growth of Two Different Dexamethasone Courses for Preterm Infants at Risk of Chronic Lung Disease

  1999cited by this paper
• Single-dose dexamethasone treatment of hypotension in preterm infants.

  1999cited by this paper
• Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants.

  1999cited by this paper
• Early (4–7 Days of Age) Dexamethasone Therapy for Prevention of Chronic Lung Disease in Preterm Infants

  1999cited by this paper
• Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants

  1999cited by this paper
• The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome.

  1998cited by this paper
• Early dexamethasone therapy in preterm infants: a follow-up study.

  1998cited by this paper
• Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

  1998cited by this paper
• Effect of Dexamethasone Therapy on the Neonatal Ductus Arteriosus

  1998cited by this paper
• The Influence of Betamethasone and Dexamethasone on Motor Development in Young Rats

  1998cited by this paper
• Role of early postnatal dexamethasone in respiratory distress syndrome.

  1998cited by this paper
• Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf.

  1997cited by this paper
• Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants

  1997cited by this paper
• Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.

  1997cited by this paper
• Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant‐substituted preterm infants

  1996cited by this paper
• Prediction of chronic neonatal lung disease on day 4 of life

  1996cited by this paper
• Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome.

  1996cited by this paper
• Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome.

  1996cited by this paper
• Influence of postnatally administered glucocorticoids on rat lung growth.

  1995cited by this paper
• Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia.

  1994cited by this paper
• Two Doses of Early Intravenous Dexamethasone for the Prevention of Bronchopulmonary Dysplasia in Babies with Respiratory Distress Syndrome

  1994cited by this paper
• The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.

  1993cited by this paper
• Growth retardation after dexamethasone administration: assessment by knemometry.

  1993cited by this paper
• Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia.

  1992cited by this paper
• Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial.

  1990cited by this paper
• Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study.

  1990cited by this paper
• Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.

  1983cited by this paper
• Using Cerebral Palsy Data in the Evaluation of Neonatal Intensive Care: a Warning

  1982cited by this paper
• The therapeutic use of glucocorticoid hormones in the perinatal period: Potential neurological hazards

  1977cited by this paper

• Dexamethasone regulates the SIRT1/NF-κB signaling pathway in neonatal rats with bronchopulmonary dysplasia to counteract NLRP3-inflammasome-induced pyroptosis and oxidative stress.

  2025cites this paper
• Prenatal corticosteroid use and offspring neurological outcomes.

  2025cites this paper
• A comprehensive analysis of clinical variables for severe bronchopulmonary dysplasia in extremely preterm infants.

  2025cites this paper
• Site-Level Fine-Tuning with Progressive Layer Freezing: Towards Robust Prediction of Bronchopulmonary Dysplasia from Day-1 Chest Radiographs in Extremely Preterm Infants

  2025cites this paper
• Association of Stress Dose Hydrocortisone with the Prevention of Bronchopulmonary Dysplasia in Extremely Preterm Neonates

  2024cites this paper
• Point prevalence, characteristics and treatment variations for preterm infants with bronchopulmonary dysplasia in China: a ‘snapshot’ study

  2024cites this paper
• Early Diagnosis of Bronchopulmonary Dysplasia with E-Nose: A Pilot Study in Preterm Infants

  2024cites this paper
• Improved Cardiac Performance with Dexamethasone Therapy in Premature Neonates: Novel Insights Using Serial Echocardiographic Assessments

  2023cites this paper
• Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia

  2023cites this paper
• Multisystem inflammatory disease in neonates (MIS-N) due to maternal COVID-19.

  2023cites this paper
• Hormonal Determinants of Growth and Weight Gain in the Human Fetus and Preterm Infant

  2023cites this paper
• Postnatal steroids as lung protective and anti-inflammatory in preterm lambs exposed to antenatal inflammation

  2023cites this paper
• Impact of postnatal steroids on peripheral avascular retina and severity of retinopathy of prematurity

  2023cites this paper
• Predictive values of clinical data,molecular biomarkers, and echocardiographic measurements in preterm infants with bronchopulmonary dysplasia

  2023cites this paper
• Combined Statin and Glucocorticoid Therapy for the Safer Treatment of Preterm Birth

  2023cites this paper
• A Dose-Limited Dexamethasone and Bubble Continuous Positive Airway Pressure in Ventilation-Dependent Extremely Premature Infants

  2022cites this paper
• Blood pressure values and hypotension management in extremely preterm infants: a multi-center study

  2022cites this paper
• Cardiorespiratory adaptation to low‐dose dexamethasone for lung disease in extremely preterm infants: A prospective echocardiographic study

  2022cites this paper
• Let’s Talk about Dex: When do the Benefits of Dexamethasone for Prevention of Bronchopulmonary Dysplasia Outweigh the Risks?

  2022cites this paper
• Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants

  2022cites this paper
• Protective Effects of Interleukin-1 Blockade on Group B Streptococcus-Induced Chorioamnionitis and Subsequent Neurobehavioral Impairments of the Offspring

  2022cites this paper
• Association of Plasma Cortisol Levels with Gestational Age and Anthropometric Values at Birth in Preterm Infants

  2022cites this paper
• Review on Prevention of Cerebral Palsy from the Perspective of Social Pediatrics

  2022cites this paper
• Antenatal corticosteroids and neurodevelopmental outcomes in late preterm births

  2021cites this paper
• Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

  2021cites this paper
• Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia

  2021cites this paper
• Neurodevelopmental Outcomes at 18–24 Months of Corrected Age in Very Low Birth Weight Infants with Late-onset Sepsis

  2021cites this paper
• Single neonatal dexamethasone administration has long-lasting outcome on depressive-like behaviour, Bdnf, Nt-3, p75ngfr and sorting receptors (SorCS1-3) stress reactive expression

  2021cites this paper
• The Miracles of Surfactant: Less Invasive Surfactant Administration, Nebulization, and Carrier of Topical Drugs

  2021cites this paper
• Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants

  2021cites this paper
• Application Prospects of Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia and the Challenges Encountered

  2021cites this paper
• A RETROSPECTIVE OBSERVATIONAL STUDY TO ASSESS THE ROLE OF FUROSEMIDE IN PREVENTION OF BRONCHO-PULMONARY DYSPLASIA IN PRETERM INFANTS(28-32WKS).

  2021cites this paper
• Midterm Neuromotor Development Results of Preterm Babies less than 34 Weeks Gestational Age

  2020cites this paper
• Preterm birth and sustained inflammation: consequences for the neonate

  2020cites this paper
• Hydrocortisone for Preventing Mortality and Bronchopulmonary Dysplasia in Preterm Infants with or without Chorioamnionitis Exposure: A Meta-Analysis of Randomized Trials

  2020cites this paper
• Bronchopulmonary Dysplasia: An Overview

  2020influential citation
• Bronchopulmonary Dysplasia: An Overview

  2020influential citation
• Bronchopulmonary Dysplasia: An Overview

  2020influential citation
• Bronchopulmonary Dysplasia: An Overview

  2020influential citation
• A PILOT STUDY ON PERINATAL OUTCOME IN ELECTIVE REPEAT CESAREAN DELIVERY AT 38 WEEKS FOLLOWING COURSE OF DEXAMETHASONE

  2020cites this paper
• Antenatal corticosteroids and the influence of sex on morbidity and mortality of preterm infants

  2020cites this paper
• A Meta-Analysis of the Effects and Safety of Pulmonary Surfactants Combined with Budesonide in Bronchopulmonary Dysplasia

  2020cites this paper
• Postnatal hydrocortisone therapy for the treatment of bronchopulmonary dysplasia in very low birth weight infants

  2019cites this paper
• Neurodevelopmental disorders among term infants exposed to antenatal corticosteroids during pregnancy: a population-based study

  2019cites this paper
• Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial

  2019cites this paper
• A Physiology-Based Approach to the Respiratory Care of Children With Severe Bronchopulmonary Dysplasia

  2019cites this paper
• Early Hydrocortisone Use and Severe Retinopathy of Prematurity in Very Low Birth Weight Infants

  2019cites this paper
• The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future.

  2019cites this paper
• Development and validation of an assay for quantifying budesonide in dried blood spots collected from extremely low gestational age neonates

  2019cites this paper
• Prophylactic postnatal corticosteroids: Early hydrocortisone.

  2019cites this paper
• Bronchopulmonary dysplasia

  2019cites this paper
• Bronchopulmonary Dysplasia: 50 Years after the Original Description

  2019cites this paper
• An Overview of Systematic Reviews of Randomized-Controlled Trials for Preventing Necrotizing Enterocolitis in Preterm Infants

  2019cites this paper
• Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants

  2019cites this paper
• Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies.

  2019cites this paper
• Glucocorticoid Therapy and Adrenal Suppression

  2019cites this paper
• Previous glucocorticoid treatment in childhood and adolescence is associated with long-term differences in subcortical grey matter volume and microstructure

  2019cites this paper
• Bronchopulmonary dysplasia

  2019cites this paper
• Late Growth and Changes in Body Composition Influence Odds of Developing Retinopathy of Prematurity among Preterm Infants

  2019cites this paper
• Specialist neonatal respiratory care for babies born preterm

  2019cites this paper
• Prenatal and Postnatal Steroids and Pulmonary Outcomes

  2019cites this paper
• Inflammation in the neonatal period and intrauterine growth restriction aggravate bronchopulmonary dysplasia.

  2019cites this paper
• Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis.

  2019cites this paper
• Extended course of prednisolone in infants with severe bronchopulmonary dysplasia.

  2019cites this paper
• O impacto na diminuição do tempo de ventilação mecânica após a implantação de um protocolo de extubação programada (check list) em recém nascidos em uma unidade de terapia intensiva neonatal

  2019cites this paper
• Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia.

  2019cites this paper
• [Research progress in drug therapy for bronchopulmonary dysplasia in preterm infants].

  2018influential citation
• Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment

  2018cites this paper
• Neonatal corticosteroid therapy affects growth patterns in early infancy

  2018cites this paper
• Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan

  2018cites this paper
• Extrem-Frühgeborene: Low-dose-Hydrocortison beeinflusst neurologische Entwicklung günstig

  2018cites this paper
• Long‐Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia

  2018cites this paper
• Rescue therapy with betamethasone in preterm infants (day of life>14) at high risk for bronchopulmonary dysplasia to assist weaning from ventilator support: a case series

  2018cites this paper
• Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies

  2018cites this paper
• Persistent and progressive long-term lung disease in survivors of preterm birth.

  2018cites this paper
• Effect of postnatal hydrocortisone on 18-month neurodevelopmental outcomes in very-low-birth-weight infants.

  2018cites this paper
• Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis

  2018cites this paper
• The effect of preterm birth on white matter tracts and infant cognition

  2018cites this paper
• Modulators of inflammation in Bronchopulmonary Dysplasia.

  2018cites this paper
• Endothelial Extracellular Vesicles in Pulmonary Function and Disease.

  2018cites this paper
• Effects of budesonide and surfactant in preterm fetal sheep.

  2018cites this paper
• Early low-dose hydrocortisone: is the neurodevelopment affected?

  2018cites this paper
• Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence

  2018cites this paper
• Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes

  2018cites this paper
• Efficacy and safety of pulmonary application of corticosteroids in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis

  2018cites this paper
• Relationship between Epigenetic Maturity and Respiratory Morbidity in Preterm Infants

  2018cites this paper
• Variability of Very Low Birth Weight Infant Outcome and Practice in Swiss and US Neonatal Units

  2018cites this paper
• Autism Spectrum Disorder and Neonatal Serum Magnesium Levels in Preterm Infants

  2018cites this paper
• Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study

  2018cites this paper
• Genetic background and antenatal risk factors of bronchopulmonary dysplasia

  2018cites this paper
• A nationwide survey on tracheostomy for very‐low‐birth‐weight infants in Japan

  2018cites this paper
• Effects of antenatal betamethasone on preterm human and mouse ductus arteriosus: comparison with baboon data

  2018cites this paper
• Biological and Social Influences on the Neurodevelopmental Outcomes of Preterm Infants.

  2018cites this paper
• Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates

  2018cites this paper
• Opportunities in posthemorrhagic hydrocephalus research: outcomes of the Hydrocephalus Association Posthemorrhagic Hydrocephalus Workshop

  2018cites this paper
• Turkish Neonatal Society guideline on prevention and management of bronchopulmonary dysplasia

  2018cites this paper
• Early Diagnosis and Treatment of Cerebral Palsy in Children with a History of Preterm Birth.

  2018cites this paper
• Usefulness of an Online Risk Estimator for Bronchopulmonary Dysplasia in Predicting Corticosteroid Treatment in Infants Born Preterm

  2018cites this paper
• Corticotrophin‐releasing hormone stimulation tests for the infants with relative adrenal insufficiency

  2017cites this paper
• Causative Organisms in Microbial Keratitis and Their Sensitivity Pattern in Kenyatta National Hospital

  2017cites this paper